Financial Performance - The estimated net profit attributable to shareholders for 2022 is projected to be between 16 million to 20 million CNY, representing a decrease of 50% to 60% compared to the previous year's profit of 40.017 million CNY[4]. Market Challenges - The decline in performance is primarily attributed to the impact of strict pandemic controls, which hindered customer visits and experiments, as well as significant disruptions in sales channels and logistics[5]. - The domestic livestock and poultry breeding market has faced ongoing challenges due to macroeconomic downturns, leading to weakened consumer demand and rising costs[6]. Product Development - New products launched in 2022 are currently in the market expansion and user cultivation phase, resulting in lower gross margins compared to older products[6]. - The company plans to accelerate nationwide market layout and new customer development, focusing on enhancing product research and development in the animal hematopoietic nutrition sector[6].
驱动力(838275) - 2022 Q4 - 年度业绩预告